Pr Christoph Scheiermann interview - Cancer treatment timing

Video Interview: Prof. Christoph Scheiermann on Circadian Rhythms and Cancer Treatment

Following the publication of their phase 3 clinical trial in Nature Medicine, GCIR Prof. Christoph Scheiermann was interviewed by CNN to discuss the implications of this research.

In this interview, he explains how circadian rhythms influence immune function, why treatment timing can significantly impact outcomes in advanced lung cancer, and how a simple adjustment in scheduling immunochemotherapy could improve survival without additional cost or toxicity.

Watch the full interview below to learn more about how biological clocks are shaping the future of cancer therapy. 

Full article: 

Huang, Z., Zeng, L., Ruan, Z. et al. Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial. Nat Med (2026).

https://doi.org/10.1038/s41591-025-04181-w
Shareable link: https://rdcu.be/e101g

©CNN News 

News